Royalty Pharma PLC

Royalty Pharma PLC(RPRX)价格预测

$60.850

-1.053 (-1.73%)收盘时

价格预测

1-Day Price Prediction
-0.68%
1-Week Prediction
-8.40%
1-Month Prediction
2026 Prediction
2030 Prediction

在 App 中打开以解锁更长周期的预测。

Loading chart…

RPRX 相似图表分析预测

Alphio's RPRX stock price prediction model matches the current Royalty Pharma PLC tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $60.44 (-0.68%). The 1-week path is $55.74 (-8.40%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

该买入 Royalty Pharma PLC 股票吗?

Royalty Pharma PLC appears to be a good buy right now due to its strong financial performance, with a year-to-date change of +56.59% and a 1-year change of +68.23%. The company has also raised its full-year guidance to $3.4 billion to $3.5 billion, indicating robust growth potential. However, the main risk is its high forward P/E ratio of 47.85, which suggests that the stock may be overvalued if growth expectations do not materialize.

RPRX 股价于 Friday 收于 $60.85,此前下跌 -1.73%

Royalty Pharma PLC (RPRX) last closed at $60.85, losing -1.73%. These facts feed the 1-day and 1-week RPRX price prediction above.

预测驱动因素

Royalty Pharma PLC(RPRX)的预测驱动因素综合了相似的图表形态、季节性与移动平均线。

Similar patterns

Positive

Bullish

Seasonality

Positive

Bullish

SMA 20

Positive

Bullish

SMA 200

Positive

Bullish

相似图表形态

近期走势与 RPRX 最接近的股票,按相似度排序。

RPRX 季节性分析

Historically the probability of a positive August return for RPRX is 69.84%. March offers the highest probability of a positive month at 100.00%, while November is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.

Loading chart…

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

免费开始